Join Growin Stock Community!

Healthequity, inc.HQY.US Overview

US StockHealthcare
(No presentation for HQY)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

HQY AI Insights

HQY Overall Performance

HQY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

HQY Recent Performance

-0.29%

Healthequity, inc.

0.05%

Avg of Sector

-0.31%

S&P500

HQY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

HQY Key Information

HQY Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

HQY Profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Price of HQY

HQY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

HQY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.22
PE Ratio (TTM)
35.09
Forward PE
17.57
PS Ratio (TTM)
5.12
PB Ratio
3.10
Price-to-FCF
18.17
METRIC
VALUE
vs. INDUSTRY
Gross Margin
67.72%
Net Margin
14.86%
Revenue Growth (YoY)
12.20%
Profit Growth (YoY)
15.96%
3-Year Revenue Growth
14.24%
3-Year Profit Growth
21.59%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.22
PE Ratio (TTM)
35.09
Forward PE
17.57
PS Ratio (TTM)
5.12
PB Ratio
3.10
Price-to-FCF
18.17
Gross Margin
67.72%
Net Margin
14.86%
Revenue Growth (YoY)
12.20%
Profit Growth (YoY)
15.96%
3-Year Revenue Growth
14.24%
3-Year Profit Growth
21.59%
  • When is HQY's latest earnings report released?

    The most recent financial report for Healthequity, inc. (HQY) covers the period of 2026Q3 and was published on 2025/10/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HQY's short-term business performance and financial health. For the latest updates on HQY's earnings releases, visit this page regularly.

  • Where does HQY fall in the P/E River chart?

    According to historical valuation range analysis, Healthequity, inc. (HQY)'s current price-to-earnings (P/E) ratio is 43.93, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of HQY?

    According to the latest financial report, Healthequity, inc. (HQY) reported an Operating Profit of 78.7M with an Operating Margin of 24.43% this period, representing a growth of 300.99% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is HQY's revenue growth?

    In the latest financial report, Healthequity, inc. (HQY) announced revenue of 322.16M, with a Year-Over-Year growth rate of 7.23%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does HQY have?

    As of the end of the reporting period, Healthequity, inc. (HQY) had total debt of 1.03B, with a debt ratio of 0.3. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does HQY have?

    At the end of the period, Healthequity, inc. (HQY) held Total Cash and Cash Equivalents of 309.26M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does HQY go with three margins increasing?

    In the latest report, Healthequity, inc. (HQY) achieved the “three margins increasing” benchmark, with a gross margin of 70.8%%, operating margin of 24.43%%, and net margin of 16%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HQY's profit trajectory and future growth potential.

  • Is HQY's EPS continuing to grow?

    According to the past four quarterly reports, Healthequity, inc. (HQY)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.6. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of HQY?

    Healthequity, inc. (HQY)'s Free Cash Flow (FCF) for the period is 127.49M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 64.11% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of HQY?

    The latest valuation data shows Healthequity, inc. (HQY) has a Price-To-Earnings (PE) ratio of 43.93 and a Price/Earnings-To-Growth (PEG) ratio of -3.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.